Access Statistics for Márta Péntek

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries? 0 0 0 27 0 4 6 42
Trading between perceived risks and benefits related to biosimilar biological treatment in Crohn’s disease; discrete choice experiment among gastroenterologists 0 0 0 29 0 1 2 75
Total Working Papers 0 0 0 56 0 5 8 117

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective 0 0 0 1 1 5 7 39
Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries 0 0 0 8 0 3 6 48
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries 0 0 0 7 0 0 2 70
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis 0 0 0 3 0 4 5 44
Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study 0 0 0 5 0 4 6 80
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison 0 0 0 2 1 1 3 36
Establishing a standard for patient-completed instrument adaptations in Eastern Europe: experience with the Nottingham Health Profile in Hungary 0 0 0 3 1 4 7 49
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary 0 0 0 4 0 2 4 60
HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain 0 0 0 7 0 0 0 37
Health economics and health technology assessment in Central and Eastern Europe: a dose of reality 0 0 0 12 0 1 2 48
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe 0 0 1 13 0 2 8 68
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe 0 0 1 12 0 6 10 61
Social/economic costs and health-related quality of life in patients with histiocytosis in Europe 0 0 0 1 0 1 2 20
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe 0 0 0 4 0 2 5 40
Social/economic costs and health-related quality of life in patients with scleroderma in Europe 0 0 0 8 1 5 8 59
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe 0 0 0 4 0 1 1 47
Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists 0 0 0 3 0 3 5 37
The disease burden of colorectal cancer in Hungary 0 0 0 23 0 0 1 133
The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries? 0 0 0 8 0 1 1 46
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries 0 0 0 0 0 2 2 26
Total Journal Articles 0 0 2 128 4 47 85 1,048

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-03-04